Literature DB >> 4586873

Glomerular complement components in human glomerulonephritis.

P J Verroust, C B Wilson, N R Cooper, T S Edgington, F J Dixon.   

Abstract

154 of 255 individual human renal biopsies studied by immunofluorescence contained varying combinations of immunoglobulins (Ig), complement (C) components C1q, C3, C4, C5, C6, C8, C3 proactivator (C3PA), and/or properdin. 10 patients had linear deposits of Ig in glomeruli characteristic of antiglomerular basement membrane (GBM) antibodies; nine patients had C3 deposits (minimal in three) with generally lesser amounts of C1q, C4, C5, C6, and/or C8. 118 of the patients had granular deposits of Ig, suggesting immune complex glomerulonephritis; 114 of these had deposits of C3, usually accompanied by C1q, C4, C5, and/or C6. These observations indicate that the entire C sequence is deposited in glomeruli in most Ig-mediated glomerulonephritides. However, certain cases of anti-GBM glomerulonephritis with few or no C deposits may utilize pathways of injury independent of C.21 patients had granular C3 deposits without detectable Ig. C5, C6, and C8 were present in the majority of these patients while C1q was absent and scant C4 was observed in only two patients. The presence of only late-acting C components in the absence of Ig, C1q, and C4 suggests selective, possible nonimmune activation of the alternate C pathway. Finally, five patients had granular deposits of C3, C5, C6, and/or C8 diffusely in all or most glomeruli with a lesser number of glomeruli having additional focal granular deposits of Ig, C1q, and C4. This observation suggests that at least two patterns of C activation can occur simulatenously, possibly triggered by antecedent immune complex deposition and then perpetuated by an as yet undetermined mechanism.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4586873      PMCID: PMC301440          DOI: 10.1172/JCI107562

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  14 in total

1.  Glomerular and dermal depostion of properdin in systemic lupus erythematosus.

Authors:  N Rothfield; H A Ross; J O Minta; I H Lepow
Journal:  N Engl J Med       Date:  1972-10-05       Impact factor: 91.245

2.  Serum complement component levels in human glomerulonephritis.

Authors:  E J Lewis; C B Carpenter; P H Schur
Journal:  Ann Intern Med       Date:  1971-10       Impact factor: 25.391

3.  The complement profile in acute glomerulonephritis systemic lupus erythematosus and hypocomplementemic chronic glomerulonephritis. Contrasts and experimental correlations.

Authors:  H Gewurz; R J Pickering; S E Mergenhagen; R A Good
Journal:  Int Arch Allergy Appl Immunol       Date:  1968

4.  Chronic glomerulonephritis associated with low serum complement activity (chronic hypocomplementemic glomerulonephritis).

Authors:  R J Pickering; R C Herdman; A F Michael; R L Vernier; H Gewurz; A J Fish; R A Good
Journal:  Medicine (Baltimore)       Date:  1970-05       Impact factor: 1.889

5.  Functional relationship of factor B in the properdin system to C3 proactivator of human serum.

Authors:  I Goodkofsky; I H Lepow
Journal:  J Immunol       Date:  1971-10       Impact factor: 5.422

6.  Glomerular deposition of properdin in acute and chronic glomerulonephritis with hypocomplementemia.

Authors:  N G Westberg; G B Naff; J T Boyer; A F Michael
Journal:  J Clin Invest       Date:  1971-03       Impact factor: 14.808

7.  Characterization of immunoglobulin G anti-glomerular basement membrane antibodies eluted from kidneys of patients with glomerulonephritis. II. IgG subtypes and in vitro complement fixation.

Authors:  J J McPhaul; F J Dixon
Journal:  J Immunol       Date:  1971-09       Impact factor: 5.422

8.  Gamma G globulin subgroup composition of the glomerular deposits in human renal diseases.

Authors:  E J Lewis; G J Busch; P H Schur
Journal:  J Clin Invest       Date:  1970-06       Impact factor: 14.808

9.  Characteristics of a non-complement-dependent C3-reactive complex formed form factors in nephritic and normal serum.

Authors:  E H Vallota; J Forristal; R E Spitzer; N C Davis; C D West
Journal:  J Exp Med       Date:  1970-06-01       Impact factor: 14.307

10.  C3 proactivator convertase and its mode of action.

Authors:  H J Müller-Eberhard; O Götze
Journal:  J Exp Med       Date:  1972-04-01       Impact factor: 14.307

View more
  24 in total

1.  Detection of glomerular complement C3 fragments by magnetic resonance imaging in murine lupus nephritis.

Authors:  Siranush A Sargsyan; Natalie J Serkova; Brandon Renner; Kendra M Hasebroock; Brian Larsen; Conrad Stoldt; Kim McFann; Matthew C Pickering; Joshua M Thurman
Journal:  Kidney Int       Date:  2011-09-28       Impact factor: 10.612

Review 2.  Complement and the Kidney: An Overview.

Authors:  Joshua M Thurman
Journal:  Adv Chronic Kidney Dis       Date:  2020-03       Impact factor: 3.620

3.  Membranoproliferative glomerulonephritis. Localization of early components of complement in glomerular deposits.

Authors:  B K Davis; T Cavallo
Journal:  Am J Pathol       Date:  1976-08       Impact factor: 4.307

4.  C4 in glomerular lesions of NZB/NZW mice.

Authors:  A E Gabrielsen; A D Simmons; U H Rudofsky
Journal:  Clin Exp Immunol       Date:  1977-02       Impact factor: 4.330

Review 5.  The membrane attack complex.

Authors:  H J Müller-Eberhard
Journal:  Springer Semin Immunopathol       Date:  1984

6.  Requirements for the solubilization of immune aggregates by complement. The role of the classical pathway.

Authors:  M Takahashi; S Takahashi; V Brade; V Nussenzweig
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

7.  C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.

Authors:  K Whaley; P H Schur; S Ruddy
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

8.  Immunohistochemical demonstration of membrane cofactor protein (MCP) of complement in normal and diseased kidney tissues.

Authors:  M Endoh; M Yamashina; H Ohi; K Funahashi; T Ikuno; T Yasugi; J P Atkinson; H Okada
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

9.  Basement membrane-changes in membranoproliferative glomerulonephritis: a light and electron microscopic study.

Authors:  D Anders; W Thoenes
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1975-12-31

Review 10.  All Things Complement.

Authors:  Joshua M Thurman; Carla M Nester
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-23       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.